Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Cell Damage”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Testing effectiveness (Phase 2)Study completedNCT00134212
What this trial is testing

Dopexamine and Norepinephrine Compared With Epinephrine Alone in Septic Shock

Who this might be right for
Septic Shock
Rennes University Hospital 20
Early research (Phase 1)Study completedNCT03890809
What this trial is testing

An Investigational Study of BMS-986165 in Participants With Normal Liver Function and Participants With Mild to Severe Liver Damage

Who this might be right for
Liver DysfunctionHealthy Volunteers
Bristol-Myers Squibb 32
Not applicableLooking for participantsNCT04036357
What this trial is testing

Liver Damage and Cardiometabolic Disorders in NAFLD

Who this might be right for
NAFLDLiver FibrosesCardiovascular Diseases+1 more
University of Roma La Sapienza 2,000
Early research (Phase 1)Study completedNCT02300025
What this trial is testing

Evaluate the Pharmacokinetics and Safety of Cobimetinib in Volunteers With and Without Liver Damage

Who this might be right for
Healthy Volunteer
Genentech, Inc. 28
Not applicableLooking for participantsNCT06318949
What this trial is testing

Albumin Modifications as Early Biomarkers of Chronic Liver Diseases

Who this might be right for
Chronic Liver Disease
University Hospital, Limoges 756
Early research (Phase 1)Study completedNCT06952634
What this trial is testing

An Investigational Study of ESK-001 in Participants With Normal Liver Function and Participants With Mild, Moderate, and Severe Liver Damage

Who this might be right for
Hepatic Impairment
Alumis Inc 32
Large-scale testing (Phase 3)UnknownNCT00658164
What this trial is testing

Effect of Iron Depletion by Phlebotomy Plus Lifestyle Changes vs. Lifestyle Changes Alone on Liver Damage in Patients With Nonalcoholic Fatty Liver Disease With Increased Iron Stores

Who this might be right for
Nonalcoholic Fatty Liver Disease
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 150
Not applicableStudy completedNCT01317342
What this trial is testing

Hypothermic Oxygenated Perfusion (HOPE) of Human Liver Grafts

Who this might be right for
Hepatocellular Injury
University of Zurich 179
Not applicableStudy completedNCT04626570
What this trial is testing

Impact of a Phone-based Cognitive and Behavioral Therapy on Food Addiction in Patients With Severe or Morbid Obesity

Who this might be right for
ObesityFood Addiction
University Hospital, Tours 154
Early research (Phase 1)Study completedNCT03679442
What this trial is testing

Macrophage Markers, Soluble CD163 (sCD163) and Soluble CD206 (sCD206) in Paracetamol Overdose

Who this might be right for
Drug-Induced Acute Liver Injury
University of Aarhus 16
Early research (Phase 1)Looking for participantsNCT07401862
What this trial is testing

Eloralintide (LY3841136) in Participants With Different Levels of Liver Damage and in Participants With Healthy Livers.

Who this might be right for
Hepatic Insufficiency
Eli Lilly and Company 36
Early research (Phase 1)Looking for participantsNCT06376474
What this trial is testing

To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage

Who this might be right for
Psoriasis
Ganzhou Hemay Pharmaceutical Co., Ltd 24
Post-approval studies (Phase 4)Study completedNCT00405301
What this trial is testing

Study of Safety and Efficacy of Different Regimes of Reintroduction of Anti-TB Drugs in Anti-TB Drugs Induced Liver Damage

Who this might be right for
Drug Induced HepatotoxicityTuberculosis
All India Institute of Medical Sciences 175
Testing effectiveness (Phase 2)Study completedNCT00003966
What this trial is testing

Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation

Who this might be right for
Veno-occlusive Disease
Dana-Farber Cancer Institute 151
Not applicableLooking for participantsNCT06869590
What this trial is testing

Identification of Anti-HIF 1alpha Autoantibodies in Patients With Anorexia Nervosa and Characterization of Their Pathogenic Potential in Undernutrition-associated Hepatic Cytolysis

Who this might be right for
Hepatic Cytolysis
Assistance Publique Hopitaux De Marseille 250
Not applicableStudy completedNCT00890448
What this trial is testing

Case Control Study of Pharmacogenomic Factors Associated With Hepatocellular Injury Following Exposure to Lapaquistat Acetate

Who this might be right for
Toxicity
Takeda 66
Not applicableStudy completedNCT03124641
What this trial is testing

HOPE for Human Extended Criteria and Donation After Brain Death Donor (ECD-DBD) Liver Allografts

Who this might be right for
Hepatocellular InjuryLiver Transplant
University Hospital, Aachen 46
Testing effectiveness (Phase 2)UnknownNCT03944447
What this trial is testing

Outcomes Mandate National Integration With Cannabis as Medicine

Who this might be right for
Chronic PainChronic Pain SyndromeChronic Pain Due to Injury+30 more
OMNI Medical Services, LLC 200,000
Not applicableStudy completedNCT01274520
What this trial is testing

Hypothermic Machine Preservation-Phase 2

Who this might be right for
Liver Damage
Columbia University 24
Large-scale testing (Phase 3)UnknownNCT02769754
What this trial is testing

Effectiveness of the Use of the New Hemostatic Patch Hemopatch ® in Patients Undergoing Surgical Liver Resection

Who this might be right for
Liver DamageSurgery
Instituto de Investigacion Sanitaria La Fe 250
Next Page